Article Detail - JE Part B
Published for Review and Comments: MolDX: Minimal Residual Disease Testing for Cancer -Proposed LCD and Billing and Coding Article
The following proposed Local Coverage Determinations (LCDs) have been published for review and comments for contract numbers: 01112 (NCA), 01182 (SCA), 01212 (AS, GU, HI, and NMI), and 01312 (NV).
|Medicare Coverage Database Number||LCD Title|
|DL38814||MolDX: Minimal Residual Disease Testing for Cancer|
|Medicare Coverage Database Number||Billing and Coding Article Title|
|DA58454||Billing and Coding: MolDX: Minimal Residual Disease Testing for Cancer|
Comment Period: October 8, 2020 – November 22, 2020
View the CMS MCD to access Proposed LCDs not released to final LCDs.
Providers may address details for comment submission. When sending comments, reference the specific policy to which they are related. See the Proposed LCDs webpage for email and mail specifics.
Last Updated Thu, 01 Oct 2020 16:09:48 +0000